ATS 2019 Virtual Final Program

P438 Using Wearables and Self-Management Apps in Patients with COPD: A Qualitative Study/ A.S. Gershon, R. Wu, S.R. Ginsburg, T. Son, Toronto, Canada, p.A2985 P439 Monitoring Daily Maintenance Medication Adherence in Patients with COPD/ B. Theye, R. Gondalia, D.A. Stempel, San Francisco, CA, p.A2986 P440 Developing a Novel Application Software for iPad that Interactively Carries Out Personalized Self-Management Education to COPD Patients Receiving Long-Term Oxygen Therapy: A Pilot Study/ K. Tamamoto, J. Ueki, E. Sano, N. Nomura, M. Ikeda, K. Hino, Y. Sano, S. Nagashima, Y. Suzuki, S. Sasaki, Urayasu, Japan, p.A2987 P441 Does Gender Influence Adherence to Inhaled Therapy in COPD? An Observational Study of Patients Treated with Indacaterol/Glycopyrronium 110/50 ug o.d. (IND/GLY)/ C. Raherison, L. Decuypere, M. Pourriel, N. Roche, Bordeaux, France, p.A2988 P442 Development and Initial Pilot Testing and Validation of a Functional-Based Health Literacy Measurement Tool for Asthma/COPD Patients/ J. Shum, I. Poureslami, R.S. Goldstein, S.K. Gupta, S.D. Aaron, W.-C. Tan, S. Pakhale, J.M. FitzGerald, Vancouver, Canada, p.A2989 P443 Lack of Association Between the Serotonin Transporter Gene Polymorphism and Depressive Symptoms in Patients with Chronic Obstructive Pulmonary Disease/ A.M. Yohannes, V. Fan, H.Q. Nguyen, K. Pike, R. Kohen, Azusa, CA, p.A2990 Facilitator : J. O’Toole, DO, Baltimore, MD P444 Lithium Therapy Is Associated with Increased Risk of COPD Exacerbation/ A. Shojaee, J.L. Gomez, M.F. Perez, New Haven, CT, p.A2991 P445 Quality of Life and Psychological Distress in Chronic Obstructive Pulmonary Disease Patients with Chronic Pain/ M. Chaabouni, W. Feki, N. Moussa, N. Bahloul, A. Kotti, W. Ketata, H. Ayadi, I. Yangui, W.K. Rekik, S. Msaed, S. Kammoun, Sfax, Tunisia, p.A2992 P446 Oxygen Payment Policy: Is It Negatively Impacting COPD Outcomes?/ C. Marquez, L. Cooper, C. Craver, G.B. Diette, T. Goss, San Diego, CA, p.A2993 P447 Informing the Pathway of COPD Treatment (the Impact Study) - Economic Evaluation of Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI or UMEC/VI in Patients with COPD by Treatment Subgroups at Screening - A Canadian Societal Perspective/ A.S. Ismaila, D. Shah, M. Schroeder, C. Abreu, A. Martin, N. Risebrough, Hamilton, Canada, p.A2994 P448 Delay in PFT Availability and Association with Obstructive Lung Disease Management in a VA Population/ T. Pham, O. Abdul-Kafi, M.J. Joo, Chicago, IL, p.A2995 P449 Epidemiology of Chronic Obstructive Pulmonary Disease in Brazil: A Systematic Review and Meta-Analysis/ M. Cruz, M. Santos, Barreiras, Brazil, p.A2996 P450 Dyspneic Older Adults with and Without Obstructive Lung Disease Have Increased Mortality/ M.T.D.G. Opina, J. Lovato, D.C. Files, B.J. Nicklas, S.B. Kritchevsky, W.C. Moore, Winston-Salem, NC, p.A2997 P451 Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in the US/ Z. Zafari, S. Li, R.M. Reed, M.N. Eakin, Baltimore, MD, p.A7370 BEHAVIORAL THEMATIC POSTER SESSION B36 ADDICTION AND TOBACCO USE IN PULMONARY AND CRITICAL CARE MEDICINE 9:15 a.m. - 4:15 p.m. KBHCCD Area A (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : H. Kathuria, MD, ATSF, Boston, MA P16 Trends in Smoking and Smoking Cessation Among People with Chronic Obstructive Pulmonary Disease (COPD)/ A.S. Gershon, J. Guanzhang, L.C. Maclagan, S.D. Aaron, Z. Yao, T.M. To, Toronto, Canada, p.A2998 P17 Addressing Barriers to Quitting Cigarettes Among Patients with Opioid Use Disorder/ D. Shankar, K. Oleinik, R. Seibert, V. Cobb, Z. Weinstein, B. Borrelli, L. Quintiliani, K. Lasser, T. Palfai, M. Gowarty, E. Helm, R.S. Wiener, H. Kathuria, Boston, MA, p.A2999 P18 Psychiatric Diagnosis and Treatment Success in a Community-Based Smoking Cessation Clinic/ L. Offit, M.M. O’Sullivan, R. Lindner, A. Rahim, New York, NY, p.A3000 P19 Predictors of Success for Smoking Cessation After an Outpatient Department Visit in Ningbo, China/ C. Cao, N. Xu, Ningbo, China, p.A3001 P20 The Impact of a Diagnosis of Alpha-1 Antitrypsin Deficiency on Smoking Cessation/ A.N. Franciosi, A. Woodsmith, L. Aldaihani, S. Lee, T.P. Carroll, N.G. McElvaney, Dublin, Ireland, p.A3002 P21 The Smoking Gun: A Multi-Variate Discriminant Analysis Model for Predicting Smoking Status/ A. Baugh, H. Simo, W. Barnett, A.S. Flora, San Francisco, CA, p.A3003 P22 Smoking Characteristics and Lung Functions Among University Athletes/ N. Saiphoklang, O. Poachanukoon, S. Soorapan, Pathumthani, Thailand, p.A3004 Facilitator : S.R. Kher, MD, Boston, MA P23 Age-Related Changes in Lung Age with Smoking Status at Two-Days Medical Checkup/ M. Fukakusa, Y. Ichikawa, Y. Ishida, K. Masuda, Tokyo, Japan, p.A3005 ATS 2019 • Dallas, TX MONDAY • MAY 20 149 MONDAY MORNING